Biomind Labs Inc.
BMND
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 10.10K | 33.20K | 46.50K | 24.30K | 129.00K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 21.00K | -- | -- | 21.00K | -- |
Total Current Assets | 31.10K | 33.20K | 46.50K | 45.20K | 129.00K |
|
|||||
Total Current Assets | 31.10K | 33.20K | 46.50K | 45.20K | 129.00K |
Net Property, Plant & Equipment | 22.30K | 24.50K | 26.80K | 29.00K | 29.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 53.40K | 57.80K | 73.30K | 74.20K | 158.00K |
|
|||||
Total Accounts Payable | 327.00K | 473.30K | 478.60K | 561.20K | 612.10K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 883.20K | 1.03M | 883.40K | 739.30K | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | 664.90K |
Total Finance Division Other Current Liabilities | 365.40K | 404.20K | 346.80K | 205.80K | -- |
Total Other Current Liabilities | 365.40K | 404.20K | 346.80K | 205.80K | -- |
Total Current Liabilities | 1.58M | 1.91M | 1.71M | 1.51M | 1.28M |
|
|||||
Total Current Liabilities | 1.58M | 1.91M | 1.71M | 1.51M | 1.28M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 883.20K | 1.03M | 883.40K | 739.30K | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.58M | 1.91M | 1.71M | 1.51M | 1.28M |
|
|||||
Common Stock & APIC | 11.43M | 11.10M | 11.10M | 11.10M | 11.10M |
Retained Earnings | -15.06M | -15.02M | -14.81M | -14.62M | -14.34M |
Treasury Stock & Other | 2.11M | 2.07M | 2.07M | 2.09M | 2.12M |
Total Common Equity | -1.52M | -1.85M | -1.64M | -1.43M | -1.12M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1.52M | -1.85M | -1.64M | -1.43M | -1.12M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.52M | -1.85M | -1.64M | -1.43M | -1.12M |
|